Switch to:

Corvus Pharmaceuticals Change In Receivables

: $0.00 Mil (TTM As of Jun. 2020)
View and export this data going back to 2016. Start your Free Trial

Corvus Pharmaceuticals's change in receivables for the quarter that ended in Jun. 2020 was $0.00 Mil. It means Corvus Pharmaceuticals's Accounts Receivable stayed the same from Mar. 2020 to Jun. 2020 .

Corvus Pharmaceuticals's change in receivables for the fiscal year that ended in Dec. 2019 was $0.00 Mil. It means Corvus Pharmaceuticals's Accounts Receivable stayed the same from Dec. 2018 to Dec. 2019 .

Corvus Pharmaceuticals's Accounts Receivable for the quarter that ended in Jun. 2020 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Corvus Pharmaceuticals's liquidation value for the three months ended in Jun. 2020 was $45.92 Mil.


Corvus Pharmaceuticals Change In Receivables Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Corvus Pharmaceuticals Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Change In Receivables Premium Member Only 0.00 0.00 0.00 0.00 0.00

Corvus Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Change In Receivables Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Corvus Pharmaceuticals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2020 was 0 (Sep. 2019 ) + 0 (Dec. 2019 ) + 0 (Mar. 2020 ) + 0 (Jun. 2020 ) = $0.00 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Corvus Pharmaceuticals  (NAS:CRVS) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Corvus Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Jun. 2020 is calculated as:

2. In Ben Graham's calculation of liquidation value, Corvus Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:

Corvus Pharmaceuticals's liquidation value for the quarter that ended in Jun. 2020 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=59.258-13.337+0.75 * 0+0.5 * 0
=45.92

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Corvus Pharmaceuticals Change In Receivables Related Terms


Corvus Pharmaceuticals Change In Receivables Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)